Human umbilical cord tissue-derived mesenchymal stromal cells as adjuvant therapy for myocardial infarction: a review of current evidence focusing on pre-clinical large animal models and early human trials
Autores da FMUP
Participantes de fora da FMUP
- Raposo, L
- Nascimento, DS
- Cardim, N
Unidades de investigação
Abstract
Although biologically appealing, the concept of tissue regeneration underlying first- and second-generation cell therapies has failed to translate into consistent results in clinical trials. Several types of cells from different origins have been tested in pre-clinical models and in patients with acute myocardial infarction (AMI). Mesenchymal stromal cells (MSCs) have gained attention because of their potential for immune modulation and ability to promote endogenous tissue repair, mainly through their secretome. MSCs can be easily obtained from several human tissues, the umbilical cord being the most abundant source, and further expanded in culture, making them attractive as an allogeneic "of-the-shelf" cell product, suitable for the AMI setting. The available evidence concerning umbilical cord-derived MSCs in AMI is reviewed, focusing on large animal pre-clinical studies and early human trials. Molecular and cellular mechanisms as well as current limitations and possible translational solutions are also discussed. (c) 2021 International Society for Cell & Gene Therapy. Published by Elsevier Inc. All rights reserved.
Copyright © 2021 International Society for Cell & Gene Therapy. Published by Elsevier Inc. All rights reserved.
Dados da publicação
- ISSN/ISSNe:
- 1477-2566, 1465-3249
- Tipo:
- Review
- Páginas:
- 974-979
- Link para outro recurso:
- www.scopus.com
Cytotherapy Elsevier Inc.
Citações Recebidas na Web of Science: 5
Citações Recebidas na Scopus: 14
Documentos
- Não há documentos
Filiações
Keywords
- cell therapy; mesenchymal stromal; stem cells; MSCs; myocardial infarction; regenerative medicine; umbilical cord; Wharton's jelly
Proyectos asociados
Estudo do tratamento da doença valvular aórtica.
Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira
Estudo Observacional Académico (AORTA) . UniC . 2019
Eficácia da transposição de um pedículo adiposo pericárdico sobre o enfarte de miocárdio em pacientes (ensaio AGTP II)
Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira
Ensaio Clínico Académico (Ensaio AGTP II) . 2019
Early Dual Antiplatelet Therapy versus Aspirin Monotherapy after Coronary Artery Bypass Surgery: survival and safety outcomes
Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira
Estudo Clínico Académico (Bypass) . 2020
Early and Midterm Outcomes following Aortic Valve Replacement with Mechanical versus Bioprosthetic Valves in Patients aged 50 to 70 Years
Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira
Estudo Clínico Académico (Aortic Valve Replacemen) . 2020
Efeito da terapêutica ß-bloqueadora pré-operatória após cirurgia de revascularização do miocárdio: sobrevida e complicações pós-operatórias
Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira
Estudo Clínico Académico . 2021
New physiological mechanisms, diagnostic and therapeutic approaches in heart failure with preserved ejection fraction.
Investigador Principal: André Pedro Leite Martins Lourenço
Estudo Clínico Académico . 2021
New Insights into Epidemiology and Pathophysiology of Abdominal Aortic Aneurysms
Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira
Estudo Clínico Académico . 2021
Impacto clínico e hemodinâmico da substituição cirúrgica da válvula aórtica por biopróteses de última geração
Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira
Estudo Clínico Académico . 2020
Condicionamento isquémico cardíaco remoto como adjuvante da revascularização miocárdia na doença coronário aguda
Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira
Estudo Clínico Académico . 2020
Citar a publicação
Raposo L,Louren?o A,Nascimento DS,Cerqueira R,Cardim N,Leite A. Human umbilical cord tissue-derived mesenchymal stromal cells as adjuvant therapy for myocardial infarction: a review of current evidence focusing on pre-clinical large animal models and early human trials. Cytotherapy. 2021. 23(11):p. 974-979. IF:6,196. (1).